Neurogenic Dysphonia/Dysphagia Registry

Stopped early

Conditions studied: Neurogenic Dysphonia, Neurogenic Dysphagia

In brief

The Neurogenic Dysphonia/Dysphagia Registry is designed to be purely observational (i.e. non-interventional, exploratory). Patient data collected from the registry is expected to be consistent with any information which can be obtained during usual care of patients with dysphonia/dysphagia treated with vocal fold augmentation.

Key facts

Study ID

NCT02493491

Run by

Merz North America, Inc.

People needed

146

Starts

2015-06-01

Expected to finish

2016-09-01

Last updated by the study team

2016-09-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and Females, ≥18 years of age
• Diagnosis of neurogenic dysphonia/dysphagia
• Under active treatment with VFA and follow-up care

You may not qualify if…

• Patients with:
• Vocal fold scar
• Laryngeal cancer defect
• Irradiation to the larynx
• Laryngeal trauma
• End-stage cancer

Where it is running

• Merz Clinical Site — La Jolla, California, United States
• Merz Clinical Site — Sacramento, California, United States
• Merz Clinical Site — Augusta, Georgia, United States
• Merz Clinical Site — Boston, Massachusetts, United States
• Merz Clinical Site — Burlington, Massachusetts, United States
• Merz Clinical Site 0010334 — New York, New York, United States
• Merz Clinical Site 0010068 — New York, New York, United States
• Merz Clinical Site 0010333 — Sleepy Hollow, New York, United States
• Merz Clinical Site — Durham, North Carolina, United States
• Merz Clinical Site 0010332 — Pittsburgh, Pennsylvania, United States
• Merz Clinical Site — Houston, Texas, United States
• Merz Clinical Site — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.